SCHEMBL22258673

SCHEMBL22258673

Clc1nc(-c2ccccc2)c2ccc3sc4c5ccccc5ccc4c3c2n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 4/20 0.41
CYP1B1 Q16678 4/20 0.41
KDM4E B2RXH2 5/20 0.41
ALDH1A1 P00352 4/20 0.41
LMNA P02545 4/20 0.41
HPGD P15428 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
GLA P06280 1/20 0.41
CYP1A2 P05177 2/20 0.39
MAPT P10636 4/20 0.39
KMT2A Q03164 4/20 0.35
OPRK1 P41145 1/20 0.35
NUDT1 P36639 2/20 0.33
L3MBTL1 Q9Y468 3/20 0.32
MEN1 O00255 3/20 0.32
MAPK1 P28482 2/20 0.32
RECQL P46063 1/20 0.32
MMP14 P50281 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
TDP1 Q9NUW8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22258684 0.90 LMNA (0.41) CYP1A1CYP1B1KDM4EALDH1A1LMNA
SCHEMBL22259099 0.89 CYP1A1 (0.41) CYP1A1CYP1B1KDM4EALDH1A1LMNA
SCHEMBL17305861 0.88 ALDH1A1 (0.41) CYP1A1CYP1B1KDM4EALDH1A1LMNA
SCHEMBL19758804 0.86 KDM4E (0.42) KDM4EALDH1A1LMNAHPGDSMN1; SMN2
SCHEMBL22258754 0.86 CYP1A1 (0.40) CYP1A1CYP1B1ALDH1A1LMNAHPGD
SCHEMBL22258707 0.83 CYP1A1 (0.38) CYP1A1CYP1B1ALDH1A1LMNAHPGD
SCHEMBL22258679 0.83 KDM4E (0.41) KDM4EALDH1A1LMNAHPGDSMN1; SMN2
SCHEMBL22258675 0.83 MEN1 (0.42) CYP1A1CYP1B1KDM4EALDH1A1LMNA
SCHEMBL17297400 0.82 ALDH1A1 (0.44) CYP1A1CYP1B1KDM4EALDH1A1LMNA
SCHEMBL17367230 0.81 ALDH1A1 (0.52) CYP1A1CYP1B1KDM4EALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11211568-B2 Compound for organic electroluminescence device using the same LUMINESCENCE TECHNOLOGY CORP. (TW) 2021-12-28 US disclosed
US-20200235311-A1 COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME LUMINESCENCE TECHNOLOGY CORPORATION (TW) 2020-07-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11211568-B2 Compound for organic electroluminescence device using the same OR10J3, PIEZO1, ICMT CYP1A1 1338/4885CYP1B1 1612/4885KDM4E 1352/4885
US-20200235311-A1 COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME OR10J3, PIEZO1, ICMT CYP1A1 1338/4885CYP1B1 1612/4885KDM4E 1352/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.